{"schema_version":"secwatch.filing_event.v1","accession":"0001816590-25-000141","form_type":"8-K","ticker":"CMPS","cik":"0001816590","company_name":"COMPASS Pathways plc","filed_at":"2025-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.566245+00:00","generated_at":"2026-05-17T01:42:20.690964+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Compass Pathways appoints Dr. Jeffrey Jonas to board; Thomas Lönngren to retire Dec 31, 2025","bullets":["Dr. Jonas appointed Board effective Oct 29, 2025; Class II director, audit and scientific committees.","Initial option for 52,000 ordinary shares vesting over 3 yrs; annual retainers $40k board, $10k audit, $6k scientific.","Thomas Lönngren to retire Dec 31, 2025 after 6+ years; no disagreements.","Dr. Jonas brings 30+ yrs neuroscience leadership; former CEO of Sage Therapeutics, partner at Cure Ventures.","Changes align with advancing COMP360 program and potential commercialization."],"urls":{"canonical":"https://secwatch.observer/filing/0001816590-25-000141","json":"https://secwatch.observer/filing/0001816590-25-000141.json","markdown":"https://secwatch.observer/filing/0001816590-25-000141.md","text":"https://secwatch.observer/filing/0001816590-25-000141.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1816590/000181659025000141/0001816590-25-000141-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1816590/000181659025000141/cmps-20251026.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:42:20.690964+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}